Merck struts drug label redesign; Hong Kong orders GSK drug recall;

> The FDA has approved Merck's redesigned drug container labels that include a new standardized format to improve readability and provide better information on product and strength differentiation. FDA release

> GSK will recall a pediatric antibiotic per Hong Kong mandate after officials found two times the limit of a plasticizer in the product. Story

> Drugmakers are urging India's prime minister to postpone implementation of a barcoding mandate to protect India from losing business to China. Item

> U.S. flu vaccine coverage reached all-time high in the 2010-2011 season. Story

> Egg-based vaccine production will likely be the main source for years to come. News

> GlaxoSmithKline will invest more than $30 million in pharmaceutical innovation and advanced manufacturing research in Mississauga, Ontario. Release

> Watson Pharmaceuticals has formally dedicated its global corporate headquarters in Parsippany, NJ. Item

Suggested Articles

South Korea’s Celltrion, which has a massive biologics site in Songdo, has decided it is time to build some operations in China.

WuXi Biologics is taking control of a Bayer plant in Germany and agreed it could serve as a backup facility for supply of hemophilia drug Kovaltry.

A Chinese OTC drugmaker gets the distinction of ringing in the new year as the first company to be slapped with an FDA warning letter.